Showing results (171-180 of 325) with videos related to
Sort By:
Pageof 33
Journal of Virology|June 2, 2021
Biochemical and Structural Properties of Entecavir-Resistant Hepatitis B Virus Polymerase with L180M/M204V MutationsShogo Nakajima, Koichi Watashi, Takanobu Kato, et al.Antimicrobial Agents and Chemotherapy|June 21, 2012
Response of simian immunodeficiency virus to the novel nucleoside reverse transcriptase inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine in vitro and in vivoMichael Murphey-Corb, Premeela Rajakumar, Heather Michael, et al.Journal of Pharmacological Sciences|November 7, 2022
Effects of a novel hepatitis B anti-viral drug E-CFCP in renal organic acid transportersMisaki Ishibane, Hirofumi Hashimoto, Meika Kaneko, et al.Microbiology Spectrum|October 11, 2022
SARS-CoV-2-Neutralizing Humoral IgA Response Occurs Earlier but Is Modest and Diminishes Faster than IgG ResponseYuki Takamatsu, Kazumi Omata, Yosuke Shimizu, et al.Bioorganic & Medicinal Chemistry Letters|August 17, 2019
Potent HIV-1 protease inhibitors incorporating squaramide-derived P2 ligands: Design, synthesis, and biological evaluationArun K Ghosh, Jacqueline N Williams, Satish Kovela, et al.Leukemia Research|September 12, 2009
Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor for elderly patients with previously untreated acute myeloid leukemiaHitoshi Suzushima, Naoko Wada, Hiroshi Yamasaki, et al.Journal of Medicinal Chemistry|August 2, 2011
Design of HIV-1 protease inhibitors with C3-substituted hexahydrocyclopentafuranyl urethanes as P2-ligands: synthesis, biological evaluation, and protein-ligand X-ray crystal structureArun K Ghosh, Bruno D Chapsal, Garth L Parham, et al.Journal of Medicinal Chemistry|April 18, 2003
Reduction of peptide character of HIV protease inhibitors that exhibit nanomolar potency against multidrug resistant HIV-1 strainsHirokazu Tamamura, Yasuhiro Koh, Satoshi Ueda, et al.Antimicrobial Agents and Chemotherapy|March 21, 2007
A novel bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI), GRL-98065, is potent against multiple-PI-resistant human immunodeficiency virus in vitroMasayuki Amano, Yasuhiro Koh, Debananda Das, et al.Biochemical and Biophysical Research Communications|December 15, 2015
Immunomodulatory drugs act as inhibitors of DNA methyltransferases and induce PU.1 up-regulation in myeloma cellsShinya Endo, Masayuki Amano, Nao Nishimura, et al.Pageof 33